KRAS and neoplasm: To determine whether targeting of TF or mTORC2 in KRAS inhibitor-resistant tumor cells could influence macrophage polarization in vitro, we performed a cell-based assay where mouse bone marrow-derived macrophages (BMDMs) were incubated with conditioned medium (CM) of HCC44 or H1792 cells.